π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This is the first human study to use X-396 (ensartinib), a drug being devel...
Status
Completed
Location
City of Hope National Med Ctr
Start Date
2012-06
Trial ID
NCT01625234
Treatments Being Tested
This was a Phase 1/2, open-label, multicenter, single-arm study of combinat...
Status
Completed
Location
Research Facility
Start Date
2017-05-10
Trial ID
NCT02898116
Treatments Being Tested
This is an open-label, Phase I single dose 2-part, crossover bioequivalence...
Status
Completed
Location
ICON - Early Development Services
Start Date
2022-11-29
Trial ID
NCT05665283
Treatments Being Tested
This is a single-center, open-label, single-dose phase I study to investiga...
Status
Unknown
Location
Jiangsu Province Hospital Affiliated to Nanjing Madical University of Medicine
Start Date
2018-12-28
Trial ID
NCT03804541
Treatments Being Tested
This study is aimed to determine the maximum tolerated dose of ensartinib, ...
Status
Completed
Location
Sun yat-sen Univerisity Cancer Center
Start Date
2017-03-06
Trial ID
NCT02959619
Treatments Being Tested